XNAS
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.
Virtual 2026 annual meeting scheduled for August signals corporate continuity despite massive revenue decline from $46M to $43M and widening losses in struggling pet pharmacy sector.
AI-generated summary — powered by BigEarnings.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-02 | Q4 2026 | -0.18 | -0.19 | -5.56% | $42.8M | ❌ Miss | -5.30% | — | — |
| 2026-02-05 | Q3 2026 | -0.13 | -0.50 | -284.62% | $40.7M | ❌ Miss | -1.72% | -1.68% | -12.42% |
| 2025-10-14 |
| Q4 2025 |
| -0.28 |
| -0.56 |
| -100.00% |
| $46.5M |
| ❌ Miss |
| — |
| — |
| — |
| 2025-02-10 | Q3 2025 | 0.00 | -0.03 | -100.00% | $53.0M | ❌ Miss | -14.04% | -14.99% | -22.01% |
| 2024-11-06 | Q2 2025 | -0.05 | 0.11 | +320.00% | $59.6M | ✅ Beat | +35.78% | +25.00% | +36.26% |
| 2024-08-06 | Q1 2025 | -0.09 | 0.18 | +300.00% | $68.0M | ✅ Beat | -14.36% | -13.55% | -8.13% |
| 2024-06-11 | Q4 2024 | -0.03 | -0.25 | -733.33% | $66.5M | ❌ Miss | -11.46% | -8.28% | -17.41% |
| 2024-04-15 | Q3 2024 | -0.01 | -0.10 | -900.00% | $65.3M | ❌ Miss | +1.46% | -1.46% | +10.22% |
Showing last 8 quarters.